Study selection
Eligible studies were randomised controlled trials (RCTs) that evaluated nurse-led care compared with usual care (any other model of care) delivered to adult patients with rheumatoid arthritis diagnosed using American College of Rheumatology criteria (revised 1988). The primary outcome of interest was disease activity. Secondary outcomes of interest were functional status (disability), quality of life, patient knowledge, patient satisfaction with care, coping with arthritis, pain, fatigue and stiffness. Nurse-led care was defined as that delivered by specialist nurses, nurse practitioners and other nurses practising in an extended role. Supplementation (nurses working alongside a doctor) and substitution (nurse working distinctly from a doctor) types of care were eligible for inclusion.
The mean age of included patients was 57 years. Mean disease duration was 8.3 years. There were three times more women than men. Interventions comprised follow-up or drug monitoring by rheumatology nurse practitioners/clinical nurse specialists. Comparators consisted of follow-up and monitoring carried out by rheumatology teams, junior doctors and through standard rheumatology care. Various outcome measures were used to assess disease activity, such as Disease Activity Score (DAS28), plasma viscosity and Ritchie Articular Index. Secondary outcomes measures varied and included the disability index of Stanford Health Assessment Questionnaire (HAQ-DI), Rheumatoid Arthritis Quality of Life Questionnaire (RAQoL) and the Research And Development (RAND) 36-item health survey. Studies were conducted in the UK and Holland.
It appeared that one reviewer selected the studies for inclusion.
Assessment of study quality
Trial quality was assessed using the Cochrane risk of bias tool for sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting and other sources of bias. Authors were contacted for information, where necessary.
Two reviewers independently assessed the quality of included trials.
Data extraction
Data were extracted to enable calculation of risk ratios for dichotomous outcomes or ratios of means (RoM) for continuous outcomes, along with 95% confidence intervals.
Data were extracted by one reviewer and checked by a second reviewer.
Methods of synthesis
Where possible, effects sizes were pooled in a meta-analysis using a random-effects model (where significant statistical heterogeneity was present assessed using the Χ² test). The remaining results were summarised in tabular form.
